Division of Diabetes, Endocrine, and Metabolism, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
J Diabetes Sci Technol. 2024 May;18(3):549-555. doi: 10.1177/19322968241235941. Epub 2024 Mar 7.
Current guidelines recommend normal saline (NS) for fluid resuscitation in the management of patients presenting with diabetic ketoacidosis (DKA). However, previous prospective studies have demonstrated improvement in patient-specific outcomes, including time to DKA resolution, when balanced crystalloid fluids are used.
We conducted a single institution, retrospective cohort study of adult patients admitted with DKA before and after a protocol change within our institution, which shifted the default resuscitative and maintenance fluid in our DKA management protocol from NS to lactated Ringer's solution (LR). The primary outcome was time from DKA clinical presentation until DKA resolution. The secondary outcome was time to discontinuation of DKA protocol insulin drip.
Of 246 patients meeting inclusion criteria, 119 were in the NS group (preprotocol change, where NS was the default resuscitative fluid) and 127 to the LR group (postprotocol change, where LR was the default resuscitative fluid). Time to DKA resolution was significantly decreased in the LR group (mean = 17.1 hours; standard deviation [] = 11.0) relative to the NS group (mean = 20.6 hours; = 12.2; = .02). Duration of DKA protocol insulin drip was shorter in the LR group (mean = 16.0 hours; = 8.7) compared with the NS group (mean = 21.4 hours; = 12.5; P < .001).
In this retrospective cohort study, protocolized DKA intravenous fluid management with LR resulted in shorter time to resolution of DKA and reduced duration of DKA protocol insulin drip.
目前的指南建议在糖尿病酮症酸中毒(DKA)患者的治疗中使用生理盐水(NS)进行液体复苏。然而,先前的前瞻性研究已经证明,当使用平衡晶体液时,患者特定的结局(包括 DKA 缓解的时间)得到改善。
我们进行了一项单机构回顾性队列研究,纳入了在我们机构改变治疗方案前后因 DKA 住院的成年患者。该方案改变了我们 DKA 管理方案中默认复苏和维持液体,将 DKA 管理方案中的默认复苏液从 NS 改为乳酸林格氏液(LR)。主要结局是从 DKA 临床表现到 DKA 缓解的时间。次要结局是 DKA 方案胰岛素滴注停止的时间。
在符合纳入标准的 246 名患者中,119 名患者在 NS 组(方案改变前,NS 是默认复苏液),127 名患者在 LR 组(方案改变后,LR 是默认复苏液)。LR 组的 DKA 缓解时间明显缩短(平均=17.1 小时,标准偏差[]=11.0),而 NS 组的 DKA 缓解时间为 20.6 小时(=12.2;=0.02)。LR 组的 DKA 方案胰岛素滴注时间更短(平均=16.0 小时,=8.7),而 NS 组的 DKA 方案胰岛素滴注时间更长(平均=21.4 小时,=12.5;P<0.001)。
在这项回顾性队列研究中,LR 方案的 DKA 静脉输液管理使 DKA 缓解时间更短,DKA 方案胰岛素滴注时间更短。